Grifols

Fuatilia
Grifols executives in boardroom approving minority stake IPO for US Biopharma business, with surging stock charts on screens.
Àwòrán tí AI ṣe

Grifols prepares stock listing for its US Biopharma business

Ti AI ṣe iroyin Àwòrán tí AI ṣe

Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ